Fundraising FoxTECLens
Stamford, US · Founded 2024 · Delaware corporation · 6 known investors
Find your way into TECLens
Sign up to see every warm intro you have to TECLens
- Paths you didn't know you had: your email and LinkedIn already hold routes to the TECLens team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
TA
Thomas Alan DunlapChief Executive Officer
DE
David E. AckerSecretary
Board
RL
Richel LiuBoard director
DM
HP
Hirak ParikhBoard director
Investors · 6
Augment VenturesreportedAnn Arbor
How we know: a partner's Signal profile · Not right? Tell us
Also in the syndicate · 4
Johnson & JohnsonleadRimonci CapitalSunmed CapitalYonjin Capitallead
Reported raises · per SEC filings
Form D private placements$15.9M disclosed across 4 rounds · 2017–2026
▶$5.2MraisedJul 2026 · 6 investors · Other Health CareRule 506(b)
▶$5.2MraisedJul 2026 · 6 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Madhu AyyagariExecutive Officer, Director
- David E AckerExecutive Officer, Director
- Patrick LopathExecutive Officer
- Hirak ParikhDirector
- Deng MaoDirector
- Richel LiuDirector
- Offering amount
- $10.2M
- Amount sold
- $5.2M
- First sale
- Jul 2026
- Incorporated
- Corporation, Delaware, 2024
- Federal exemptions
- 06b
▶$9.3MraisedMar 2025 · 4 investors · Other Health CareRule 506(b)
▶$9.3MraisedMar 2025 · 4 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- David E. AckerExecutive Officer, Director
- Patrick LopathExecutive Officer
- Thomas Alan DunlapExecutive Officer, Director
- Richel LiuDirector
- Deng MaoDirector
- Hirak ParikhDirector
- Offering amount
- $9.3M
- Amount sold
- $9.3M
- Proceeds to insiders
- $430.3K
- First sale
- May 2024
- Incorporated
- Corporation, Delaware, 2024
- Federal exemptions
- 06b
▶$200KraisedFeb 2019 · 1 investors · Other Health CareRule 506(b)
▶$200KraisedFeb 2019 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- David AckerDirector
- Offering amount
- $1.5M
- Amount sold
- $200K
- First sale
- Feb 2019
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
▶$1.2MraisedJun 2017 · 3 investors · Other Health CareRule 506(b)
▶$1.2MraisedJun 2017 · 3 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- David AckerDirector
- Offering amount
- $4M
- Amount sold
- $1.2M
- First sale
- May 2017
- Incorporated
- Limited Liability Company, Delaware, 2013
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are TECLens's investors?
- TECLens's investors include Augment Ventures, Johnson & Johnson Innovation – JJDC.
- How much funding has TECLens raised?
- TECLens has disclosed $15.9M raised across 4 rounds.
- Where is TECLens headquartered?
- TECLens is headquartered in Stamford, US.